Paul Jones, LPN | |
6822 East / 1000 South, Fort Duchesne, UT 84026 | |
(435) 725-6858 | |
(435) 722-9137 |
Full Name | Paul Jones |
---|---|
Gender | Male |
Speciality | Licensed Practical Nurse |
Location | 6822 East / 1000 South, Fort Duchesne, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225400534 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | PN5172605 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Paul Jones, LPN Po Box 160, Fort Duchesne, UT 84026-0160 Ph: (435) 725-6858 | Paul Jones, LPN 6822 East / 1000 South, Fort Duchesne, UT 84026 Ph: (435) 725-6858 |
News Archive
The University of Western Sydney's MARCS Auditory Laboratories is leading the way with groundbreaking research, exploring the auditory abilities of infants, so hearing aids can correctly amplify the frequencies that babies need to develop communication and language skills.
The Telethon Institute for Child Health Research study is the first to show low levels of the vitamin in utero can harm a child's language development, including the ability to pick up new words and string together sentences.
Ampio Pharmaceuticals, Inc. announced today that the FDA has accepted the Company's IND for Optina™ for the treatment of diabetic macular edema (DME). Ampio plans to commence enrollment in a clinical trial in the first quarter of 2013. The FDA granted Optina™ 505(b)(2) status in July, 2012. Drugs designated under this pathway can be approved on a single trial.
GW Cancer Research Team in the Department of Biochemistry and Molecular Biology, in the School of Medicine and Health Sciences, published a study that is the first of its kind to use mRNA sequencing to look at the expression of genome, at a unprecedented resolution at the current time, in three types of breast cancer.
› Verified 6 days ago